Patents by Inventor Elizabeth Gleason

Elizabeth Gleason has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzimidazole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof
    Publication number: 20060106081
    Abstract: The invention relates to benzimidazole acetic acid compounds which function as antagonists of the Chemoattractant Receptor-homologous molecule expressed on T-Helper type 2 cells (CRTH2) receptor. The invention also relates to the use of these compounds to inhibit the binding of prostaglandin D2 and its metabolites or certain thromboxane metabolites to the CRTH2 receptor and to treat disorders responsive to such inhibition.
    Type: Application
    Filed: September 21, 2005
    Publication date: May 18, 2006
    Inventors: Youssef Bennani, Lawrence Tumey, Elizabeth Gleason, Michael Robarge
  • Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof
    Publication number: 20060100425
    Abstract: The invention relates to indole acetic acid compounds which function as antagonists of the CRTH2 receptor. The invention also relates to the use of these compounds to inhibit the binding of prostaglandin D2 and its metabolites or certain thromboxane metabolites to the CRTH2 receptor and to treat disorders responsive to such inhibition.
    Type: Application
    Filed: September 21, 2005
    Publication date: May 11, 2006
    Inventors: Youssef Bennani, Lawrence Tumey, Elizabeth Gleason, Michael Robarge